Download Presentation (PDF 1.24 MB) - Linde Engineering

Gases Division, sales by product areasSolid performance in a more challenging environmentin € million, comparable* (consolidated)HealthcareTonnage8,638 +3.3%*913 +13.3%*2,109 +2.3%*8,9221,0342,158HealthcareIncluding € 231 m of Lincare, thegrowth rate is 38.6% in HealthcareTonnageBulk**2,476+2.6%*2,540Adjusted for the negative impactsfrom plant shut downs comparablegrowth would be 6.0%, includingjoint ventures 7.4%Cylinder**3,140+1.6%*3,190Bulk & CylinderSofter volume development visible9M 2011*excluding currency, natural gas price effect and Lincare9M 2012** due to changed reporting structure of around € 390 m are shifted from Cylinder to Bulk7

Group, solid financial positionA year of significant investmentsLincare acquisition: Refinancing activities— € 3.6 bn acquisition facility already reduced to slightly below € 1 bn— Take-out measures include € 1.4 bn capital increase and two debt capital marketstransactions totaling around € 1.3 bnNet debt (€ m)5.13.48.5Net debt/EBITDA1.62.5Financing Environment— Financing atvery low interestrates on along-term basis31/122011Increase30/0920122011LTM— Low spreadsrealised in therefinancing processCredit Ratings— Standard&Poor’s: A/A-1 with stable outlook (04 July 2012*)— Moody’s: A3/P-2 with stable outlook (02 July 2012*) * date of latest rating agency publication10

Business PerformanceHPO 2013 - 2016: € 750 – 900 m additional gross cost savings— HPO 2009 to 2012: Fully on track and already within the target range— HPO 2013 to 2016: Further continuation of the standardisation and optimisationprocesses within an extended footprintAccumulated gross cost savings in € millionHPO 2009 to 2012HPO 2013 to 2016Target Range 650 - 80080Target Range 750 - 900SG&A620~15%~35%Procurement 30%~20%Bulk SupplyChain2009-2011H1 2012H2 2012Cylinder Supply Chain11

Group, dividendsDividend increased by 13.6% to € 2.50+13.6%€2.50€2.20+22.2%+5.9% €1.80 stable €1.80+13.3%€1.70Change inOperatingProfit€1.50+18.1%*+5.4%-6.7%+22.6%+9.7%2006 2007 2008 2009 2010 2011* comparable change: prior year figures including twelve months of BOC12

Agenda1. Operational and Financial Performance2. Strategic Focus:— Growth Markets— Energy / Environment— Healthcare3. OutlookAppendix13

Mega-trendsLeveraging growth with our Gases & Engineering set-up14

Mega-trend Growth MarketsStrong investments in future growthGrowth Markets exposurefurther increasedGrowth Market sales (% of Gases sales)Majority of Capex 2011invested in Growth MarketsGases Capex 2007 – 2011 in € bn36%35%1.51.31.432% 32%34%33%1.10.60.81.00.60.70.629%0.50.70.40.60.82007200820092010201120072008200920102011Excl. JVsIncl. JVsMature MarketsGrowth Markets15

Mega-trend Growth MarketsMarket leader in 4 out of 5 Growth MarketsGood position led to strong growth since 2007Industrial gases market 2011 vs. 2020 in € bn~5%~5~2%~23%~9%~16~23~13~10~5 ~5~2# 1~16~16~6# 1~9%~4%~4%~1%~12%~5%~5 ~5~2~1~0.5# 2 # 1~10~4# 1~2~1Linde average revenue growth 2007-2011Average GDP growth 2007-2011Growth Markets in € bn2011 2020Mature Markets in € bn2011 2020Source: Linde database, figures excl. Japan, equipment, healthcare andmajor impact out of future growth markets of the energy/environment sector16

Gases Division, project pipelineCurrently € 2.6 billion under execution— € 4.7 bn investments between 2009-2015 (thereof € 0.6 bn in JVs @ share)— Project amount for 2013 to 2015 increased by around € 650 m— Around 70% of total project-capex allocated to Growth Markets— Amount of project opportunities remains at € 4.3 bn on a high levelProject amount by on-stream date (incl. JVs) in € m~800 ~800~750 ~750~600~500~5002009201020112012201320142015(Projects > € 10 m)Status: 30/06/201217

Mega-trend Growth MarketsComprehensive strategy to capture growth potential in AsiaConsolidated sales in Asia in € mMajor investment commitments in Asia LTMGreaterChina20112010576701+22%Yantai, China (Q3/2011)- On-site supply contract with Wanhua Polyurethanes Co., Ltd.- Two large scale ASUs: ~€ 130 m capex, on-stream date 2013/2014*South &East Asia20112010975861+13%Wu´an, China (Q4/2011)- On-site supply contract with Hebei Puyang Iron and Steel Ltd.- Decaptivation of 7 ASUs with energy efficiency upgrade andconstruction of a new ASU: ~ € 120 m capex, on-stream date 2014*Pakistan#1Bangladesh#1China #1KoreaTaiwanJilin, China (Q4/2011)- On-site supply contract with Evonik Industries and Jilshen- Hydrogen plant (SMR): ~€ 42 m capex, on-stream date 2013/2014*Dalian, China (Q1/2012):- On-site supply contract with chemical producer Dahua Group- Decaptivation of 2 ASUs: investment ~ € 70 m, on-stream date 2014*#1India#1Sri Lanka#1ThailandSingaporeIndonesia#1#1Vietnam#1PhilippinesMalaysiaKalinganagar, India (Q2/2012)- On-site supply contract with Tata Steel,- Two large scale ASUs: ~€ 80 m capex, on-stream date 2014*Ba Ria, Vietnam (Q3/2012)- On-site supply contract with POSCO SS-Vina,- Largest ASU in Vietnam: ~€ 40 m capex, on-stream date 2014** to be expected18

Mega-trend Energy/EnvironmentImportance of new technologies & industrial gases applicationsGlobal energy consumption*Energy/Environment annual market revenue estimates*700Renewables500NuclearCoal300100Natural GasPetroleum Liquids2010 2015 2020 2030Source: U.S. Energy Information Administration€ 80 -140 bn€ 14 -19 bn€5 -7 bnCLEAN COALCO2 HANDLINGH2 FUELINGRENEWABLES (e.g. BIOMASS GASIFICATION, PHOTOVOLTAIC)CO2 emission reduction— Fossil resources remain dominantenergy source— Fossil resources becoming scarce—CO2-emissions steadily increasing— Importance of renewable energyincreasing but still limited reach*in quadrillion British Thermal Units (equals around 10 27 Joules)LNGEOR (N2 / NRU / CO2), GTL2015 2020 2030Increasing energy consumption & CO2 emissionAnnual market revenue in the respective yearPilot projects and small volumes*Assuming 100% Build Own Operate and excluding sale of equipment and plants(Please find assumptions for estimates on page 50)19

Mega-trend Energy/EnvironmentOpportunities in shale gas business: Example USNatural gas processing plantActive major shale gas fieldsin the USAExpected development of US shale gasproduction in the next decade (in Bcf)Barnett5.5Fayetteville4.5Woodford 2.0Haynesville8.0Marcellus4.5Bcf = billion cubic feetSource: EIA, “Oil and Gas Field Maps”; Linde database; NavigantEngineering— Total order intake since 2010 more than USD 1.1 bn— Opportunities within the field of shale gas:— Natural gas processing plants: driven by the necessity of gas treatment for pipeline and bulk use— Small-mid-scale LNG plants: driven by increasing demand for merchant LNG— Ethane crackers: driven by increasing chemical production— Gases-to-liquids (GTL)Gases— Potential leverage of our operation experience into the area of shale gas— Based on shale gas new chemical clusters develop with the need for industrial gases supply20

Mega-trend HealthcareMarket leader in an attractive industryRelevant Healthcare growth areas 2011 vs. 2020 in € bn, Linde market position# 1~5.7~8.1 ~3.9 # 2~5.82.2~2.2~1.0# 1Mature Markets in € bn2011 2020Growth Markets in € bn2011 2020Source: Linde, figures incl.gas therapies and intermediate careMarket environmentGrowing, ageing population and under-diagnosed diseasesIncreasing wealth in Growth MarketsHealthcare budget pressure and regulation21

Mega-trend HealthcareFrom medical gas provider to solutions & service providerDevelopment of new therapies and applicationsHospital CareGas TherapiesIntermediate CareHomecare— Gas supply andtechnical assistance— Logistics andinstallation— Customer service— Hospital & medicalgas services— Pulmonaryhypertension &cardio-thoracicsurgery— Oxygen & helioxtherapies— Pain relief— REMEO: treatmentand care of chronicpatients withmechanicalventilation needs— Home oxygentherapies— Ventilation— Sleep therapy— Nutrition/Infusion— INR monitoring— Specialtypharmaceuticalservices22

Agenda1. Operational and Financial Performance2. Strategic Focus:— Growth Markets— Energy / Environment— Healthcare3. OutlookAppendix23

Gases, CapexDevelopment Capex Sales Ratio 2007-201115%Capex/Sales Ratio12%11%13% 13%~1,900average2011-201413% plus*1,4511,3261,4391,0621,029Capex in € m2007 2008 2009 2010 20112012Data 2007-2011 @ actual average fx rates at the end of the respective year* plus: additional potential for mega-projects24

Outlook*Profitable Growth.2012GroupGasesEngineering— Growth in sales and operating profit vs. 2011— Confirmation of HPO-programme 2009-2012:€ 650-800 m of gross cost savings— Sales increase vs. 2011— Continuous improvement of productivity— Sales at the same level as in 2011— Operating margin of at least 10%Mid-termGroupGases— 2013: Operating profit of at least € 4 bn— 2015: Adjusted** ROCE of 14% or above— Continuation of HPO-programme 2013-2016:€ 750-900 m of gross cost savings— Average capex/sales ratio 13% plus— Revenue increase above market growth— Further increase in productivity* based on current economic predictions and prevailing exchange rates **please see definitions on page 5525

UBS European Conference 2012Your questions are welcome.

Agenda1. Operational and Financial Performance2. Strategic Focus:— Growth Markets— Energy / Environment— Healthcare3. OutlookAppendix27

Group, Q3 2012Key P&L itemsin € million Q3 2011 Q3 2012 ∆ in %Revenue 3,435 3,889 13.2Operating profit 804 908 12.9Operating margin 23.4% 23.3% -10 bpEBIT 481 494 2.7PPA depreciation -60 -59 1.7EBIT before PPA depreciation 541 553 2.2Financial result -89 -77 13.5Taxes -87 -90 -3.4Net income 305 327 7.2Net income – attributable to Linde AG shareholders 290 313 7.9EPS in € 1.70 1.70 0.0Adjusted EPS in € 1.89 1.89 0.028

Group, 9M 2012Key P&L itemsin € million 9M 2011 9M 2012 ∆ in %Revenue 10,209 11,063 8.4Operating profit 2,363* 2,563 8.5Operating margin 23.1 23.2 10 bpEBIT 1,399 1,467 4.9PPA depreciation -181 -181 -EBIT before PPA depreciation 1,580 1,648 4.3Financial result -215** -240 -11.6Taxes -281 -269 4.3Net income 903 958 6.1Net income – attributable to Linde AG shareholders 856 904 5.6EPS in € 5.02 5.15 2.6Adjusted EPS in € 5.68 5.80 2.1*including € 16 m one-time effect from changes to the UK pension plan**including positive one-time effect of € 30 m (repayment of BOC Edwards vendor loan)29

Group, FY 2011Key P&L itemsin € million 2010 2011 ∆ in %Sales 12,868 13,787 7.1Operating Profit 2,9253,210 9.7Margin 22.7%23.3% +60 bpEBIT before PPA depreciation 1,9332,152 11.3PPA depreciation -254-242 5.0EBIT 1,6791,910 13.8Financial Results -280-291 -3.9Taxes -335-375 -11.9Net income 1,064 1,244 16.9Net income – Part of shareholders Linde AG 1,0051,174 16.8EPS in € 5.946.88 15.8Adjusted EPS in € 6.897.71 11.930

Gases Division, operating segmentsQuarterly dataEMEA (€ m)Q1 2011Q1 2012 Q2 2011Q2 2012Q3 2011Q3 2012Sales1,3931,445 1,4311,4991,4341,528Operating profit*395414 412420408431Operating margin28.4%28.7% 28.8%28.0%28.5%28.2%Asia/Pacific (€ m)Q1 2011Q1 2012 Q2 2011Q2 2012Q3 2011Q3 2012Sales707808 766866810937Operating profit*196218 210235228244Operating margin27.7%27.0% 27.4%27.1%28.1%26.0%Americas (€ m)Q1 2011Q1 2012 Q2 2011Q2 2012Q3 2011Q3 2012Sales580625 593636605889Operating profit*136152 134160135210Operating margin23.4%24.3% 22.6%25.2%22.3%23.6%*EBITDA incl. share of profit or loss from associates and joint ventures31

GroupFinancial key indicators again on record levelsProfitable growth for our shareholders— adjusted EPS up by 11.9%— adjusted ROCE further improved by 50 bp€5.464.58€Adjusted* EPS Adjusted* ROCE Operating Cash Flowin € m, as reported€6.896.89€€4.587.71€12.5%13.0%2,1422,4222,42610.4%2009201020112009201020112009 20102011*please see definitions on page 5432

GroupFinancial Result and Tax RateFinancial Result (in € m)Tax Rate38532928029122.9%22.1%23.9%23.2%20082009 2010 2011200820092010201133

Group, 9M 2012Cash Flow Statementin € million Q1 2012 Q2 2012 Q3 2012 9M 2012 9M 2011Operating profit 808 847 9082,5632,363Change in Working CapitalOther changesOperating Cash FlowInvestments in tangibles/intangiblesAcquisitions/Financial investmentsOtherInvestment Cash FlowFree Cash Flow before FinancingInterests and swaps, Dividends-318-105385-321-343-281104-68-101-262484-384-65524-1,015*-531-592-42-229637-452-2,34142-2,751*-2,114-140-461-5961,506-1,157-2,999109-4,047*-2,541-800-114-5501,699-893-55116-832*867-685Capital increase 1,391 1,391Other changes -33 44 -463 -452Net debt increase (+)/decrease (-) -3 1,079 1,326 2,402*excluding proceeds on disposal of securities € 553 m in Q2 2012; € 298 m in Q3 2012; and payments for investments in securities € -600 m in 9M 20119-19134

Group, FY 2011Cash Flow Statementin € million Q1 2011 Q2 2011 Q3 2011* Q4 2011*2011* 2010Operating profit 761 798 804 847 3,210 2,925Change in Working CapitalOther changesOperating Cash FlowInvestments in tangibles/intangiblesAcquisitions/Financial investmentsOtherInvestment Cash FlowFree Cash Flow before FinancingInterests and swapsDividends and other changesNet debt increase (+)/decrease (-)-180-141440-237-1343-207233-45-2-1866-267537-310-133-278259-114-38524060-142722-346-4140-347375-123-7-24539-159727-452-2353-422305-56-11-238-75-7092,426-1,345-78169-1,2541,172-338-405-42984-5872,422-1,192-68195-1,0651,357-298-280-779* excluding investments in securities of € 600 m in Q3 and € 1,052 m in Q435

Group, solid financial positionEarly refinancing of existing financial debtContinuous efforts to extend the Group’s maturity profile— Issuance of € 500 m 7 years senior notes in June 2012— More than 80% of total financial debt is due beyond 2012— Approx. 56% of total financial debt has a longer maturity than 5 years2%7%19% 10%1%2%67%72%4,3443Other Bonds2,880Subordinated Bonds(*callable in 2013/2016)2,147224Commercial Paper1,277Bank Loans132 349 1,9231,461796Balanced mix of various financing instruments— Strong focus on long-term bond financing— Strategic funding in EUR, GBP, USD and AUDFinancial debt, by maturity (in € m)< 1 year1 - 5 years> 5 yearsFinancial debt,by instrumentFigures as of 31 December 201136

Group, PensionsPerformance and key figures 2011Net obligationPerformance of major pension plansin € millionDBOPlanasset4,467Pension plan assets portfolio structureNetobligation01/01/2011Service costsNet financingActuarial losses/gainsContributions/payments4,97188253335–213254153–1350488-1182–200Other -33 -19 -1431/12/2011 5,401 4,842 559*United Kingdom12.3%11.6%6.0%Germany14.6%12.8%5.0%201012%57% 25%20111% 5%12% 64%1% 3%20%2011 expected2011 actual2009 -2011 avg.2011 expected2011 actual2009 -2011 avg.Fixed-intrest securitiesEquitiesOthers Insurance Property* Figure does not include effects from asset ceiling (€ 26 m) and provisions for similar obligations (€ 26 m)37

Gases Division, sales bridge9M 2012 sales: price/volume increase of 3.3%in € million+2.7%9,153+3.3%*+4.5%+0.2%8,2709M 2011CurrencyNatural GasPrice/VolumeLincare9M 2012*including € 113 m changes in consolidation38

Gases DivisionJoint venturesin € millionProportionate Sales(not incl. in the Group top-line)Share of Net Income(contribution to operating profit)+18.9%+31.0%32338458769M 20119M 20129M 20119M 201239

Gases Division, Split of CapexGrowth Markets Capex increased to above 50 percentSplit Capex by operating segmentsin € million1,439+8.5%1,326Growth MarketsSplit Capex by markets2011616+1.8%627EMEA201054% 46% 54% 46%492+19.3%587Asia/Pacific218+3.2%225AmericasMature Markets2010201140

Gases DivisionFrom source to customerGas production centreOn-site supplyCustomerPipelineTonnageTransport of liquefied gasCustomerBulkFilling stationCustomerRetailerCylinder transportCylinder41

Gases DivisionVarious distribution mix served from one product sourceTonnageGlobal #2HealthcareGlobal #2— 15-year take-or-pay contracts(incl. base facility fees)— Add. growth in JVs & EmbeddedFinance Lease projects24%24%(21%*)24%24%(21%*)2011Sales11%(23%*) 11%41% 41%(35%*)— Hospital care & Homecare— Bulk & cylinder gases— Structural growth— Multi-year contracts— Application-drivenBulkGlobal #1> 70% of revenues from> 30% market shareCylinderGlobal #1— High customer loyalty— Includes specialty gases— Cylinder rentals* Pro forma Linde & Lincare figures 2011; based on exchange rates of 1.25€/$42

Gases DivisionStabilitydrivenbya broadcustomerbase2011: Split of product areas by major end-customer groups 2011: Split of sales bymajor end-customer groupsTonnageChemistry & EnergyFood & BeveragesMetallurgy & GlassElectronics OtherManufacturingElectronicsBulk22% Chemistry & EnergyMetallurgy & GlassRetailOtherFood & Beverages20% ManufacturingChemistry & EnergyChemistry & EnergyMetallurgy & Glass14% Metallurgy & GlassHomecareManufacturing12% Retail11% HealthcareHealthcareHospital CareOtherRetailElectronicsCylinder9% Food & Beverage5% Electronics7% Other43

Gases Division, local business model70% of revenues come from a leading market positionMarket leader in 55 of the 75 major countries,#2 Player in another 11Sales split by market shareBulk & Cylinder€7.1 bn*< 30%≥ 30%≥ 40%70%≥ 60%Market Leader #2 Player OthersStatus 2012*Sales of Bulk & Cylinder FY 201144

Engineering DivisionLeading market position in all segmentsAir Separation PlantsHydrogen & SynthesisGas PlantsPetrochemical PlantsNatural Gas PlantsWorldwide #1 Worldwide #2 Worldwide #2 Worldwide #3Production of plants for Linde Gas and3rd party customersProviding chemistry and energy related solutionsto 3rd party customersLE LocationsProject companies, rep.and sales officesSupporting the energy/environmental mega-trend and leveraging customer relations for gas projects45

Engineering DivisionKey figures FY 2011in € millionOrder Intakein € millionSales+3.5%+2.8%2,1592,2352,4612,5312010201120102011in € millionOperating Profit*+12.3%Operating Margin+100 bp27130411.0%12.0%2010201120102011*EBITDA incl. share of net income from associates and joint ventures46

Engineering DivisionFY 2011 order intake by plant type and regionOrder Intake by Plant TypeOrder Intake by Region201020112010201128.3%Air SeparationPlants25.7%57.2%EMEA32.4%16.2%Hydrogen/Synthesis GasPlants21.5%28.5%16.7%10.3%Olefin PlantsNatural GasPlantsOther15.8%23.4%13.6%27.2%15.6%ASIA/PACIFICAMERICAS44.1%23.5%47

Mega-trend Growth Markets – ChinaA diverse customer portfolio to match an integrated businessOil/PetrochemicalsChemicalsMetallurgyElectronicsHealthcareOthers48

Mega-trend Growth Markets – ChinaIntegrated offer in selected industrial polesIntegrated ClustersExample – NingboGases productssupply to bulk andcylinder marketsPipeline linkage (key concept)Fully Integrated ClusterMultiple customers suppliedby pipeline (GAN/GOX/GHY)Integrated plant operationB O CZhenhaiGAN pipelineGOX pipelineDaxie IslandB O CB O CB O CBeilunBO CBO CB O C49

Clean Energy market estimation 2020 & 2030top downMarket size in € bn2015 2020 2030 Assumptions for 2030Clean Coal --- ---20 – 40– Triple-digit number of 1 GW Carbon Capture(1.5 Gt/a CO 2at EUR 25-40/t)CO 2networks small 115 – 25– Installation of significant pipeline network and correspondingcompression(1.5 Gt/a handling fee CO 2at EUR 10-15/t)H 2fueling small 110 – 15EOR/EGR* 1.5 4 - 518 – 35LNG 3 - 4 6 - 1011 – 23Renewables 1 2Range 5 - 7 14 - 19 80 - 1403– Installation of a significant fuel station infrastructure– Corresponding annual H 2consumption of some bn tonsp.a.– Single to double digit number of large N 2EOR/NRU projects– Double digit number of large CO 2EOR projects includingindustrial CO 2capture and pipeline (overlapping w/CCS)– Based on penetration rate of LNG replacing existing fuels– Merchant LNG projects based on geographical set up andexisting infrastructure– Floating LNG projects– Includes mainly gases used for manufacturing ofphotovoltaic cells* Assuming 100% Build Own Operate and excluding sale ofequipment and plantsGeneral assumptions:— Market numbers are directional only and w/o inflation or currency— Oil price development at 80-100 USD/bll— Outsourced gases market only (excl. captive market or equipment sales)50

Mega-trend HealthcareLincare – the performance leader in the Homecare industry— 1,091 locations— More than 800,000 patients— 35 Billing/Collections Offices— 31 Pharmacies— 11,000 employees— 1,320 in Billing/Collections— 1,166 in SalesLeading player in the US— 2011: USD 1.8 bn sales and USD 454 m EBITDA— Leading provider in the highly fragmentedUS industry— Pure play in respiratory: ~90% of sales— 28% of 2011 share of industry revenues— National platform offers full US coverage— Scale and efficiency advantagesEstablished brand with strong reputation— High-quality products and services forpatients and providers— Top-class billing processes and IT-systems— Strong sales force with superior relationshipsto referral sourcesBest-in-class sales growth track record— CAGR in 2002-2011 of 7.5%— Managing price cuts through customer gains— Disciplined industry consolidator utilizingstrong cash flow51

Mega-trend HealthcareLincare – Industry leader with balanced business & payor mixLeading Industry PositionBusiness MixPayor MixLincare11%Apria13%28%Rotech9%Oxygen50%Medicare49%AHOM6%18%localplayers61%7%4%43%SpecialtyServicesSleep ApneaInfusion/EnteralOther22%17%6%5%MedicaidPrivateInsuranceDirect12%32%7%1998201120112011Source: Lincare investor presentation52

Mega-trend HealthcareLincare – Ageing population & service duration in the USThe average oxygen patient is 75 years of age2030: 19% of the population older than 65 years of ageU.S. Population Trends and Projections for age 65+, 1980-2030 *in millionsIncreasing service durationsupports structural growthService Duration Oxygen in monthsFirst Baby-Boomersturn 65 years oldFirst Baby-Boomersturn 75 years old34.028.425 40557221.91980 2010 20202030* Years 2010 through 2030 are projections200020052011Source: U.S. Department of Commerce, Bureau of the CensusSource: Lincare investor presentation53

GroupBOC PPA – Expected Depreciation & Amortisation— Development of depreciation and amortisation— Impact in 9M 2012: € 181 million— Expected range adjusted due to exchange rate effectsExpected range in € m2012 230 – 2552013 200 – 225…2022 < 125BOC PPA Depreciation Planning (in € m)40030020010002006 2008 2010 2012 2014 2016 2018 2020 2022 202454

Group, definition of financial key figuresOperatingProfitadjustedROCEReturnReturnEBITDA (incl. IFRIC 4 adjustment)excl. finance costs for pensionsexcl. special itemsincl. share of net income from associates and joint venturesOperating profit- depreciation / amortisationexcl. depreciation/amortization from purchase price allocation*adjustedEPSAverageCapitalEmployedReturnequity (incl. minorities)+ financial debt+ liabilities from finance leases+ net pension obligations- cash, cash equivalents and securities- receivables from finance leasesearnings after tax and minority interests+ depreciation/amortization from purchase price allocation*+/- special itemsSharesaverage outstanding shares*adjustment for the effects of the purchase price allocation on the acquisition of BOC only55

Investor RelationsContactPhone: +49 89 357 57 1321eMail: investorrelations@linde.comInternet: www.linde.comFinancial Calendar— Full year report 2012: 07 March 2013— Q1 report 2013: 06 May 2013— Annual General Meeting: 29 May 201356